when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

Oncology · news · pharmadog

← back to Oncology

News · Oncology

910 stories

May 28, 26GSK, Ionis unveil data for hepatitis B drug touted as ‘functional cure’biopharma dive

May 28, 26AbbVie clinches FDA approval for ultra-rare blood cancer ADC from ImmunoGen purchaseendpoints

May 27, 26AstraZeneca's breast cancer PDUFA delayed; Arrowhead aims at same obesity target as Waveendpoints

May 22, 26FDA Approves First Treatment for Chronic Hepatitis Delta Virus (HDV) Infectionfda press

May 19, 26A migraine drugmaker heads to the public markets through reverse mergerbiopharma dive

May 19, 26Relay drug shows early promise against rare blood vessel diseasesbiopharma dive

May 19, 26Relay's PI3Kα inhibitor clears efficacy bar in Phase 2 vascular anomalies studyendpoints

May 18, 26Merck ADC, licensed from China, hits mark in first big global trialbiopharma dive

May 18, 26Regeneron reaches $125M Parabilis deal for hard-to-catch drug targetsendpoints

May 18, 26Høeg fired in latest FDA shakeup; 20 people die after taking Amgen drugbiopharma dive

May 18, 26Regeneron immunotherapy combo comes up short in melanoma trialbiopharma dive

May 18, 26Texas is opening up a detransition clinicstat

May 18, 26Regeneron's Phase 3 skin cancer miss adds to mounting failures in LAG-3endpoints

May 17, 26In Ebola outbreak, a number of Americans in the Congo believed to have had exposure to suspected casesstat

May 17, 26When should you get a mammogram? Conflicting advice makes it hard to knowstat

May 16, 26Dr Hafron on a Multidisciplinary Quality Initiative Designed to Mitigate the AEs of ADT in Prostate Canceronclive

May 16, 26Opinion: Marty Makary misunderstood something fundamental about the FDAstat

May 15, 26FDA Approves T-DXd for Early-Stage HER2+ Breast Canceronclive

May 15, 26Dr Garzotto on Aglatimagene Besadenovec Plus Valacyclovir and EBRT in Localized Prostate Canceronclive

May 15, 26STAT+: FDA leadership shakeup widens following Makary’s departurestat

May 15, 26Dr Hafron on the FDA Approval of Adjuvant Atezolizumab in MRD+ MIBConclive

May 15, 26Durvalumab Plus BCG Reduces High-Risk NMIBC Recurrence or Death Risk by 32% in Phase 3 POTOMAC Trialonclive

May 15, 26Darolutamide Plus ADT Yields Significant OS Benefit in mHSPConclive

May 15, 26OncLive Weekly News Quiz (5/15/2026): Did You Catch 3 New FDA Oncology Approvals?onclive

May 15, 26Pembrolizumab Plus BCG Elicits 92% CR Rate in BCG-Naive Very High-Risk T1 NMIBConclive

May 15, 26FDA Approves Adjuvant Atezolizumab for MRD+ Muscle-Invasive Bladder Canceronclive

May 15, 26Roswell Park Team Members Take Part in Global Conference Dedicated to Indigenous Peoples and Canceronclive

May 15, 26Biotech leaders campaign for Pazdur; Takeda to lay off 4,500 workersbiopharma dive

May 15, 26Candel reports prostate cancer drug's long-term data ahead of FDA filingendpoints

May 15, 26Poll Findings Highlight the Most Anticipated GU Cancer Abstracts at ASCO 2026onclive

← prevpage 22 of 31next →